Synergistic Effects of Dexamethasone and Dexmedetomidine in Extending the Effects of Pectoral I and Pectoral II Blocks for Postoperative Analgesia Following Total Mastectomy with Lymph Node Dissection.
Ahish ChitneniJamal HasoonIvan UritsOmar ViswanathAlan David KayeJonathan EskanderPublished in: Clinics and practice (2021)
Regional anesthesia is an important aspect of the overall anesthetic plan for patients. It has the potential to offer superior benefits compared to opioid-based treatment and is an important component of Enhanced Recovery after Surgery (ERAS) protocols. The use of the pectoral type I (PECS I) and pectoral type II blocks (PECS II) has been shown to reduce postoperative pain and opioid consumption in patients undergoing complete mastectomy and breast surgery. We describe the use of dexamethasone and dexmedetomidine to prolong the analgesic effects of these regional blocks in a patient undergoing total mastectomy with lymph node dissection.
Keyphrases
- postoperative pain
- patients undergoing
- pain management
- chronic pain
- end stage renal disease
- breast reconstruction
- lymph node
- rectal cancer
- low dose
- newly diagnosed
- high dose
- radical prostatectomy
- ejection fraction
- minimally invasive
- cardiac surgery
- chronic kidney disease
- prostate cancer
- prognostic factors
- peritoneal dialysis
- squamous cell carcinoma
- coronary artery bypass
- case report
- cancer therapy
- spinal cord injury
- acute kidney injury
- acute coronary syndrome
- radiation therapy